{"title":"Synthesis and in vitro/in silico evaluation of the antimalarial activity of potential amino-quinoline derivatives","authors":"Moussa Touré , Abdoulaye Gassama , Oumar Sambou , Christian Cavé , Sandrine Cojean","doi":"10.1016/j.ejmcr.2024.100241","DOIUrl":null,"url":null,"abstract":"<div><div>In this study, a series of <em>N</em>-arylamino-7-chloroquinolines were synthesized via an alkylation reaction involving aniline derivatives <strong>(2)</strong> and 4,7-dichloroquinoline <strong>(1)</strong>. Additionally, the synthesis of a library of <em>N</em>-aryl-<em>N</em>-benzylamino-7-chloroquinoline analogues, modified on the aniline nitrogen, has also reported. A structure-activity relationship (SAR) study was conducted to evaluate the biological efficacy and safety of these derivatives against chloroquine-sensitive (<em>Pf</em>3D7) and chloroquine-resistant (<em>Pf</em>W2) <em>Plasmodium falciparum</em> strains. Compounds <strong>5i</strong> and <strong>5c</strong> showed promising efficacy against the <em>Pf</em>3D7 strain with IC<sub>50</sub> values of 0.25 μM and 0.54 μM, respectively, while compound <strong>5l</strong> demonstrated significant activity against the <em>Pf</em>W2 strain with an IC<sub>50</sub> of 5.82 μM. The cytotoxicity of these compounds was also evaluated on HUVEC cell lines. Additionally, their pharmacological and pharmacokinetic (ADME) properties were studied to predict their fate and identify promising candidates for further clinical studies.</div></div>","PeriodicalId":12015,"journal":{"name":"European Journal of Medicinal Chemistry Reports","volume":"13 ","pages":"Article 100241"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772417424001134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In this study, a series of N-arylamino-7-chloroquinolines were synthesized via an alkylation reaction involving aniline derivatives (2) and 4,7-dichloroquinoline (1). Additionally, the synthesis of a library of N-aryl-N-benzylamino-7-chloroquinoline analogues, modified on the aniline nitrogen, has also reported. A structure-activity relationship (SAR) study was conducted to evaluate the biological efficacy and safety of these derivatives against chloroquine-sensitive (Pf3D7) and chloroquine-resistant (PfW2) Plasmodium falciparum strains. Compounds 5i and 5c showed promising efficacy against the Pf3D7 strain with IC50 values of 0.25 μM and 0.54 μM, respectively, while compound 5l demonstrated significant activity against the PfW2 strain with an IC50 of 5.82 μM. The cytotoxicity of these compounds was also evaluated on HUVEC cell lines. Additionally, their pharmacological and pharmacokinetic (ADME) properties were studied to predict their fate and identify promising candidates for further clinical studies.
本研究以苯胺衍生物(2)和4,7-二氯喹啉(1)为原料,通过烷基化反应合成了一系列n -芳基- n -苄基氨基-7-氯喹啉类似物。此外,在苯胺氮上修饰的n -芳基- n -苄基氨基-7-氯喹啉类似物库也有报道。通过构效关系(SAR)研究评价了这些衍生物对氯喹敏感(Pf3D7)和耐氯喹(PfW2)恶性疟原虫的生物有效性和安全性。化合物5i和5c对Pf3D7菌株的IC50值分别为0.25 μM和0.54 μM,化合物5l对PfW2菌株的IC50值为5.82 μM,具有较好的抑制作用。在HUVEC细胞株上评价了这些化合物的细胞毒性。此外,研究了它们的药理学和药代动力学(ADME)特性,以预测它们的命运,并确定有希望进行进一步临床研究的候选药物。